Lumen Technologies Inc (LUMN)

Total Costs & Expenses

$12.23B

TTM · Period ending: · USD

LUMN logo

LUMN Total Costs & Expenses

Latest reported$12.23B
LUMN TTM Total Costs & Expenses (-$96.80M → $12.23B)
High-resolution chart · PNG

LUMN total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lumen Technologies Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
12,230,000,000
13,032,000,000
13,214,000,000
13,148,000,000
13,040,000,000
12,483,000,000
12,653,000,000
12,862,000,000
13,185,000,000
22,129,000,000
22,232,000,000
25,932,000,000
26,113,000,000
17,731,000,000
17,976,000,000
14,578,000,000
14,735,000,000
14,953,000,000
15,402,000,000
18,650,000,000
19,173,000,000
19,544,000,000
19,750,000,000
17,539,000,000
17,916,000,000
18,229,000,000
18,621,000,000
18,791,000,000
19,059,000,000
19,592,000,000
20,147,000,000
20,053,000,000
18,676,000,000
17,264,000,000
15,647,000,000
14,745,000,000
14,985,000,000
15,010,000,000
15,139,000,000
14,967,000,000
15,078,000,000
15,200,000,000
15,295,000,000
15,525,000,000
15,522,000,000
15,538,000,000
15,621,000,000
15,575,000,000
15,780,000,000
15,704,000,000
15,550,000,000
15,558,000,000
15,293,000,000
15,438,000,000
15,663,000,000
15,869,000,000
16,079,000,000
16,071,000,000
13,346,421,000
10,459,027,000
7,655,773,000
4,916,681,000
4,903,967,000
4,957,083,000
5,210,679,000
4,487,797,000
3,741,138,000
2,918,928,000
1,892,932,000
1,885,322,000
1,878,395,000
1,899,471,000
1,914,773,000
1,895,512,000
1,863,163,000
1,809,545,000
1,775,780,000
1,761,507,000
1,782,192,000
1,796,275,000
1,801,235,000
1,777,884,000
1,742,849,000
1,711,414,000
1,668,581,000
1,661,694,000
1,653,419,000
1,656,655,000
1,656,616,000
1,644,739,000
1,630,349,000
1,607,264,000
1,561,074,000
1,430,275,000
1,338,387,000
1,340,071,000
1,368,856,000
1,481,619,000
1,559,550,000
1,546,237,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.